Quantcast

Latest chronic pancreatitis Stories

2009-04-19 09:39:39

An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #494)Thymoquinone, the major constituent of the oil extract from a Middle Eastern herbal seed called Nigella sativa, exhibited anti-inflammatory properties that reduced the release of...

2009-01-06 16:55:55

Anti-oxidant supplements can effectively relieve pain in patients with chronic pancreatitis, researchers in India say. In the double blind trial, published in Gastroenterology, 127 patients with chronic pancreatitis were assigned to placebo or anti-oxidant groups. After six months, the reduction in the number of painful days/month was significantly higher in the anti-oxidant group than in the placebo group. The reduction in the number of analgesic tablets/month was also higher in the...

2009-01-02 08:21:32

Convincing evidence to recommend antioxidants for treatment has been lacking Antioxidant supplementation was found to be effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis (CP), reports a new study in Gastroenterology. CP is a progressive inflammatory disease of the pancreas in which patients experience abdominal pain (in early stage) and diabetes and maldigestion (in late stage). Pain is the major problem in 90 percent of patients with...

2008-10-23 09:00:10

Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that the Trizytek( TM) (liprotamase) Phase 3 efficacy study results will be presented at oral and poster sessions at the 2008 North American Cystic Fibrosis Conference (NACFC) in Orlando, FL on October 23 and 24. Trizytek is a non-porcine derived enzyme replacement therapy for patients with pancreatic insufficiency. The Phase 3 Trizytek efficacy results will be presented by Dr. Drucy Borowitz, Professor of Clinical Pediatrics, State...

2008-09-24 09:00:13

By Herrmann, Ken Eckel, Florian; Schmidt, Stefan; Scheidhauer, Klemens; Krause, Bernd Joachim; Kleeff, Joerg; Schuster, Tibor; Wester, Hans- Juergen; Friess, Helmut; Schmid, Roland M; Schwaiger, Markus; Buck, Andreas K We have determined the ability of PET with the thymidine analog 3'-deoxy-3'-^sup 18^F-fluorothymidine (FLT) to detect pancreatic cancer and to differentiate malignant from benign pancreatic lesions. Methods: In this prospective study, ^sup 18^F-FLT PET was performed on 31...

2008-09-04 09:00:09

By Fuentes-Orozco, Clotilde Cervantes-Guevara, Gabino; Mucino- Hernandez, Ivette; Lopez-Ortega, Alejandro; Ambriz-Gonzalez, Gabriela; Gutierrez-de-la-Rosa, Jose Luis; Gomez-Herrera, Efrain; Hermosillo-Sandoval, Jose Manuel; Gonzalez-Ojeda, Alejandro Background: The effect of parenteral GLN on recovery from severe acute pancreatitis has not been thoroughly investigated. The aims of this study were to determine whether parenteral GLN improves nutrition status and immune function, and to...

2008-08-29 03:00:19

By Kim, Tad Grobmyer, Stephen R; Dixon, Lisa R; Hochwald, Steven N We present an interesting case of a 62-year-old woman with a 3- month history of vague, left-sided abdominal pain. CT imaging revealed a hypodense lesion in the tail of the pancreas. The patient had no history of pancreatitis or autoimmune diseases. Laboratory testing revealed a normal CA19-9 (33 U/mL) and an elevated IgG4 (133 mg/dL). Due to concerns of pancreatic malignancy, she underwent operation. We found a dense,...

2008-08-11 18:00:14

Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that its Phase 3 efficacy trial of Trizytek(TM) (porcine-free enzymes) in patients with cystic fibrosis (CF) successfully met its primary endpoint of improvement in fat absorption. The Company released top-line results from its 163 patient, double-blind, placebo-controlled trial of Trizytek, an enzyme replacement therapy for patients with pancreatic insufficiency. Trizytek is a stable and pure combination of three active enzymes in a...

2008-08-05 18:00:09

By CAROLINE INNES LIVERPOOL doctors are to pioneer new treatments for one of the most deadly forms of cancer after landing pounds 5m worth of funding. Liverpool is to be one of only three cities in the country to receive the windfall for a new Biomedical Research Unit (BRU) to specialise in pancreatic and digestive diseases which claim hundreds of lives each year. Pancreatic digestive diseases develop in over 50,000 people per year in the UK, causing major illness and death and...

2008-06-18 18:00:08

PHILADELPHIA, June 18, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Company's New Drug Application (NDA) for EUR-1008 (pancrealipase capsules) for the treatment of exocrine...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.